Hematologic and Cytogenetic findings in eleven Chronic Myelogenous Leukemia Patients treated with Imatinib Mesylate at a Tertiary Care Hospital

Journal of the Pakistan Medical Association

Volumn 54, Issue 1, 2004, Pages 17-20

  Usman, M ^a   Kakepoto, G N ^a   Adil, S N ^a   Sajid, R ^a   Arain, S ^a   Khurshid, M ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ADULT; AGED; ARTICLE; BLAST CELL CRISIS; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHEMOTHERAPY INDUCED EMESIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; DRUG RESPONSE; EDEMA; FEMALE; FLUID RETENTION; HEMATOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOBLAST COUNT; LYMPHOCYTE COUNT; MALE; METAPHASE; NAUSEA; ORBIT DISEASE; PERIORBITAL EDEMA; PHILADELPHIA 1 CHROMOSOME; SIDE EFFECT;

ADULT; ANTINEOPLASTIC AGENTS; CYTOGENETICS; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PIPERAZINES; PYRIMIDINES; TREATMENT OUTCOME;

EID: 1542406359     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Stefan F, Moshe T, Zeev E, et al. The biology of chronic myeloid leukemia. Review article. N Engl J Med 1999;341:164-72.
2. Gordon MY, Goldman JM. Cellular and molecular mechanisms in chronic myeloid leukemia: biology and treatment. Br J Hematol 1996; 95: 10-20.
3. Holyoake TL. Recent advances in the molecular and cellular biology of chronic myeloid leukemia: lessons to be learned from the laboratory. Br J Hematol 2001;113:11-23.
4. Sawyers CL. Chronic myeloid leukemia, medical progress; review article. N Engl J of Med 1999;340:1330-40.
5. Gleevec (Imatinib Mesylate) prescribing information. Novartis Pharmaceutical Corporation, East Hanover, New Jersey: May 2001.
6. Mughal TL, Goldman JM. Chronic myeloid leukemia: ST1-571 magnifies the therapeutic dilemma. Eur J Cancer 2001;37:561-8.
7. Kantarjian H, Sawyers CL, Andreas H, et al. Hematological and cytogenetic responses to Imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002;346:645-52.
8. Braziel RM, Teresa M, Brian J, et al. Hematopathologic and cytogenetic findings in Imatinib-treated chronic myelogenous leukemia:14 months' experience. Blood, 2002;100:435-42.
9. Druker BJ, Sawyers CL, Kantarjian H, et al. Activity of a specific inhibitor of the bcr-ab1 tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001;344:1038-43.
10. Sawyers CL. Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Semin Hematology 2001;38:15-21.